Benchmark Holdings (BMK)

Sector:

Pharma and Biotech

35.60p
   
  • Change Today:
    -3.40p
  • 52 Week High: 48.00p
  • 52 Week Low: 34.00p
  • Currency: UK Pounds
  • Shares Issued: 739.79m
  • Volume: 118,205
  • Market Cap: £263.37m
  • Beta: 0.48

Benchmark gets two new salmon broodstock licences in Norway

By Josh White

Date: Tuesday 10 Oct 2023

LONDON (ShareCast) - (Sharecast News) - Aquaculture biotechnology specialist Benchmark Holdings announced on Tuesday that it has obtained two new salmon broodstock licences from the Directory of Fisheries in Norway.
The AIM-traded company said the licences, collectively allowing for the production of 780 tons of salmon broodstock, were a pivotal development in expanding its production capabilities.

It said the two licences were distinctly allocated for different production environments - one permitting up to 360 tons for sea production and the second enabling the company to produce up to 420 tons on land.

That would double Benchmark's current licensed production volume and strategically diversify its operations across various sites.

"Benchmark's genetics operations are core to our ability to supply highly bio-secure salmon eggs to salmon producers year round," said chief executive officer Trond Williksen.

"The grant of the new licences is a reflection of Benchmark's leading position in the industry, track record and quality of our operations.

"The two new licences enable us to further increase security of supply of bio-secure, high quality eggs with high performing genetic traits for our customers supporting our mission to drive sustainability in aquaculture."

At 1113 BST, shares in Benchmark Holdings were down 2.88% at 37.1p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

BMK Market Data

Currency UK Pounds
Share Price 35.60p
Change Today -3.40p
% Change -8.72 %
52 Week High 48.00p
52 Week Low 34.00p
Volume 118,205
Shares Issued 739.79m
Market Cap £263.37m
Beta 0.48

BMK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
19.67% below the market average19.67% below the market average19.67% below the market average19.67% below the market average19.67% below the market average
32.00% above the sector average32.00% above the sector average32.00% above the sector average32.00% above the sector average32.00% above the sector average
Price Trend
32.77% below the market average32.77% below the market average32.77% below the market average32.77% below the market average32.77% below the market average
30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average
Income Not Available
Growth
10.03% above the market average10.03% above the market average10.03% above the market average10.03% above the market average10.03% above the market average
17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BMK Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
13:45 3 @ 35.64p
12:40 44 @ 36.00p
11:41 5,682 @ 36.00p
11:41 6,318 @ 36.00p
11:38 7,236 @ 35.61p

BMK Key Personnel

Chair Peter George
CFO Septima Maguire
CEO Trond Williksen

Top of Page